VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Activity
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

49 hedge funds and large institutions have $91.9M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 7 closing their positions.

Holders
49
Holders Change
+16
Holders Change %
+48.48%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
8
Reduced
17
Closed
7
Calls
$925K
Puts
$800K
Net Calls
+$125K
Net Calls Change
-$171K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$14.1M
2
BI
2
BVF Inc
California
$28.6M
3
SB
3
Samsara BioCapital
California
$7.69M
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$5.99M
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$5.99M

Top Sellers

1
MIM
1
Monashee Investment Management
Massachusetts
$784K
2
ACM
2
Aisling Capital Management
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.92M
4
RM
4
RP Management
New York
$34K
5
NMC
5
NEA Management Company
Maryland
$343K
Name Market Value Shares Shares
Change 		Shares
Change %
BWP
51
Baldwin Wealth Partners
Massachusetts
$0 47 -119 -72%
PA
52
Parallel Advisors
California
$0 8 -24 -75%
TWA
53
TCI Wealth Advisors
Arizona
– – -2 Closed
Simplex Trading
54
Simplex Trading
Illinois
– – – –
CFGS
55
Concourse Financial Group Securities
Alabama
– – – –
VFA
56
Valeo Financial Advisors
Indiana
$0 17 +2 +13%
Fidelity Investments
57
Fidelity Investments
Massachusetts
$0 14 +14 New
HI
58
Harbour Investments
Wisconsin
$0 42 +42 New
1 2
3